Tender Offer
What Drives Biotech M&A? Understanding Why Big Pharma Acquires Small Biotechs
Biotech M&A headlines are among the most consistently exciting news events in the sector — a large pharmaceutical company announces an acquisition of a smaller biotech, often at a premium of 50%, 80%, or well over 100% above the target’s prior trading price. Understanding what drives these acquisitions, how they are structured, and how to…
